H19 and chronic myelogenous leukemia, BCR-ABL1 positive: As a precursor of miR-675, imprinting of the lncRNA H19 controls mouse hematopoietic stem cell quiescence and is highly associated with chronic myeloid leukemia, chronic myelomonocytic leukemia, and acute myelogenous leukemia [21–23].